Constipation Treatment Market to Grow at a CAGR of 5.9% to reach US$ 13,386.19 Million from 2020 to 2027

report image

Constipation Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C Agonists, and 5-HT4 Receptor Agonists); Disease (Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation, and Opioid-Induced Constipation); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography

Publication Month: Sep 2020 | Report Code: TIPRE00005408 | No. of Pages: 175 | Category: Pharmaceuticals | Status: Published

The constipation treatment market is expected to reach US$ 13,386.19 million in 2027 from US$ 8,533.89 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020-2027.


Constipation is a chronic disorder that results in indifferent bowel movements and usually leads to hardened feces that persists for several weeks or even longer. This usually occurs when the colon has absorbed excessive water from the food that's is in the colon.
The report offers insights and in-depth analysis of the constipation treatment market, emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading global market players. The market has been segmented on the basis of therapeutic, disease, distribution channel, and region. Based on region, the market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America.

Lucrative Regions for Constipation Treatment Market

Lucrative Regions for Constipation Treatment Market

Get more information on this report :


Market Insights

Rising Prevalence of Chronic Constipation

Constipation is a commonly seen health condition among all age groups across the world. According to the article ‘Chronic Constipation’ published in May 2018, worldwide, the prevalence of constipation is estimated to be 16%. It is estimated to be varying between 0.7% to 79%. Also, the prevalence of constipation is higher among people age 60 years and above. The attributed prevalence of constipation to this age group is 33.5%.

Several factors are associated with the rising prevalence among older people, which include lack of normal bowel movements due to progressive age, improper diet and fluid intake, and inadequate physical activity. Whereas, among adults, the common cause of constipation is stress, lack of exercise, endocrine disorders, colon diseases, neurological dysfunction, and other causes such as environmental and pharmaceutical conditions.

The prevalence of constipation across the world varies substantially due to the different ethnic groups and perceptions. For instance, according to the article ‘What is the worldwide prevalence of constipation?’ published in March 2020, in North America, ~63 million people are affected by chronic constipation. Likewise, ~12% of people across the world live with self-defined constipation. The data also stated that people in the Americas and the Asia Pacific the prevalence is twice the European region. Constipation causes psychological morbidity and results in low quality of life. Thus, it essential to diagnose, manage, and treat constipation is very important. Therefore, the rising prevalence of constipation is expected to drive the demand for medicines treating constipation, further lead to the growth of the market.

Therapeutic-Based Insights

Based on therapeutic, the constipation treatment market is segmented into laxatives, chloride channel activators, peripherally acting mu-opioid receptor antagonists, GC-C agonists, and 5-HT4 receptor agonists. The laxatives segment held the largest share of the market in 2019. However, GC-C agonists segment is anticipated to register the highest CAGR in the market during the forecast period.

Constipation Treatment Market, by Therapeutic – 2019 and 2027

Constipation Treatment Market, by Therapeutic – 2019 and 2027

Get more information on this report :


Disease Insights

Based on disease, the constipation treatment market is segmented into chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. The chronic idiopathic constipation segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.

Distribution Channel Insights

Based on distribution channel, the constipation treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR of 6.4% in the market during the forecast period.

Strategic Insights

Report Coverage - Constipation Treatment Market
Report CoverageDetails
Market Size Value inUS$ 8,533.89 Million in 2019
Market Size Value byUS$ 13,386.19 Million by 2027
Growth rateCAGR of 5.9% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages175
No. of Tables72
No. of Charts & Figures69
Historical data availableYes
Segments coveredTherapeutic ; Disease ; Distribution Channel , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Inorganic strategies such as partnerships, mergers, and acquisitions are commonly adopted by companies to cater to changing customer demand worldwide, which also allows them to maintain their brand name. The constipation treatment market players have been adopting organic strategies such as product launches and expansions to expand their footprint and product portfolios.

By Therapeutic

  • Laxatives
  • Chloride Channel Activators
  • Peripherally Acting Mu-Opioid Receptor Antagonists
  • GC-C Agonists
  • 5-HT4 Receptor Agonists

By Disease

  • Chronic Idiopathic Constipation
  • Irritable Bowel Syndrome With Constipation
  • Opioid-Induced Constipation

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America (SCAM)
    • Brazil
    • Argentina

Company Profiles

  • AbbVie's Inc
  • Takeda Pharmaceutical Company Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Mallinckrodt Plc
  • Abbott
  • Cosmo Pharma
  • Sanofi
  • Albireo Pharma, Inc,
  • AstraZeneca

Frequently Asked Questions

Constipation is a chronic disorder that leads to indifferent bowel movements, usually leading to hardened faeces that persist for several weeks or even longer. This usually happens when the colon absorbs excessive water from the colon food.
Key factors that are driving growth of the market are increasing research and development for the development of new drugs, improving healthcare infrastructure in various emerging economies, increasing awareness among end-users, growing geriatric population, increasing fast-food consumption and unhealthy lifestyle.
The product's cost varies depending upon the type of drugs, such as branded (innovative) or generic and form such as tablets, syrup, and powder. The price of products also varies depending upon the countries. For instance, the cost of Amitiza oral capsule 8 mg is the ~ US $397 for 60 capsules in the US. Whereas the price for laxative is different from the tablet, for instance, MOVICOL 1 sachet is US$ 0.80 (83.90 yen) in Japan. Similarly, the price of Dulcolax Laxative Tablets for 50 tablets is nearly US$ 6, whereas it cost US$ 0.94 (0.80 €) for one tablet.

The List of Companies - Constipation Treatment Market

  1. AbbVie Inc.
  2. Takeda Pharmaceutical Company Limited
  3. Bausch Health
  4. Bayer AG
  5. Mallinckrodt
  6. Abbott
  7. COSMO PHARMACEUTICALS
  8. Sanofi
  9. Albireo Pharma, Inc
  10. AstraZeneca
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Constipation Treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Constipation Treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00005408
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount